New Two-Pronged attack on devastating ALS nerve disease
Disease control
Recruiting now
This study is testing an investigational combination therapy called COYA 302 for adults with Amyotrophic Lateral Sclerosis (ALS). It aims to see if the treatment is safe and can slow the progression of the disease by targeting inflammation in the body. About 120 participants will…
Phase: PHASE2 • Sponsor: Coya Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC